Last reviewed · How we verify
paraurethral injection of MDCs
paraurethral injection of MDCs is a Biologic drug developed by Royan Institute. It is currently in Phase 1 development. Also known as: MDCs transplantion by paraurethral injection..
At a glance
| Generic name | paraurethral injection of MDCs |
|---|---|
| Also known as | MDCs transplantion by paraurethral injection. |
| Sponsor | Royan Institute |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- paraurethral injection of MDCs CI brief — competitive landscape report
- paraurethral injection of MDCs updates RSS · CI watch RSS
- Royan Institute portfolio CI
Frequently asked questions about paraurethral injection of MDCs
What is paraurethral injection of MDCs?
paraurethral injection of MDCs is a Biologic drug developed by Royan Institute.
Who makes paraurethral injection of MDCs?
paraurethral injection of MDCs is developed by Royan Institute (see full Royan Institute pipeline at /company/royan-institute).
Is paraurethral injection of MDCs also known as anything else?
paraurethral injection of MDCs is also known as MDCs transplantion by paraurethral injection..
What development phase is paraurethral injection of MDCs in?
paraurethral injection of MDCs is in Phase 1.
Related
- Manufacturer: Royan Institute — full pipeline
- Also known as: MDCs transplantion by paraurethral injection.
- Compare: paraurethral injection of MDCs vs similar drugs
- Pricing: paraurethral injection of MDCs cost, discount & access